Birukova Anna A, Shah Alok S, Tian Yufeng, Moldobaeva Nurgul, Birukov Konstantin G
Lung Injury Center, Section of Pulmonary and Critical Medicine, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Lung Injury Center, Section of Pulmonary and Critical Medicine, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Cell Signal. 2016 Jun;28(6):541-51. doi: 10.1016/j.cellsig.2016.02.015. Epub 2016 Feb 24.
Endothelial cell (EC) barrier disruption induced by edemagenic agonists such as thrombin is a result of increased actomyosin contraction and enforcement of focal adhesions (FA) anchoring contracting stress fibers, which leads to cell retraction and force-induced disruption of cell junctions. In turn, EC barrier enhancement by oxidized phospholipids (OxPAPC) and other agonists is a result of increased tethering forces due to enforcement of the peripheral actin rim and enhancement of cell-cell adherens junction (AJ) complexes promoting EC barrier integrity. This study tested participation of the mechanosensitive adaptor, vinculin, which couples FA and AJ to actin cytoskeleton, in control of the EC permeability response to barrier disruptive (thrombin) and barrier enhancing (OxPAPC) stimulation. OxPAPC and thrombin induced different patterns of FA remodeling. Knockdown of vinculin attenuated both, OxPAPC-induced decrease and thrombin-induced increase in EC permeability. Thrombin stimulated the vinculin association with FA protein talin and suppressed the interaction with AJ protein, VE-cadherin. In contrast, OxPAPC stimulated the vinculin association with VE-cadherin. Thrombin and OxPAPC induced different levels of myosin light chain (MLC) phosphorylation and caused different patterns of intracellular phospho-MLC distribution. Thrombin-induced talin-vinculin and OxPAPC-induced VE-cadherin-vinculin association were abolished by myosin inhibitor blebbistatin. Expression of the vinculin mutant unable to interact with actin attenuated EC permeability changes and MLC phosphorylation caused by both, thrombin and OxPAPC. These data suggest that the specific vinculin interaction with FA or AJ in different contexts of agonist stimulation is defined by development of regional actyomyosin-based tension and participates in both, the barrier-disruptive and barrier-enhancing endothelial responses.
由诸如凝血酶等致水肿激动剂诱导的内皮细胞(EC)屏障破坏是肌动球蛋白收缩增加以及锚定收缩应力纤维的粘着斑(FA)增强的结果,这会导致细胞回缩以及力诱导的细胞连接破坏。反过来,氧化磷脂(OxPAPC)和其他激动剂引起的EC屏障增强是由于外周肌动蛋白边缘增强以及促进EC屏障完整性的细胞间粘附连接(AJ)复合物增强导致的束缚力增加的结果。本研究测试了机械敏感衔接蛋白纽蛋白(它将FA和AJ与肌动蛋白细胞骨架偶联)在控制EC对屏障破坏(凝血酶)和屏障增强(OxPAPC)刺激的通透性反应中的作用。OxPAPC和凝血酶诱导了不同模式的FA重塑。纽蛋白敲低减弱了OxPAPC诱导的EC通透性降低以及凝血酶诱导的EC通透性增加。凝血酶刺激纽蛋白与FA蛋白踝蛋白的结合,并抑制其与AJ蛋白血管内皮钙黏蛋白的相互作用。相反,OxPAPC刺激纽蛋白与血管内皮钙黏蛋白的结合。凝血酶和OxPAPC诱导了不同水平的肌球蛋白轻链(MLC)磷酸化,并导致了细胞内磷酸化MLC分布的不同模式。肌球蛋白抑制剂blebbistatin消除了凝血酶诱导的踝蛋白-纽蛋白结合以及OxPAPC诱导的血管内皮钙黏蛋白-纽蛋白结合。无法与肌动蛋白相互作用的纽蛋白突变体的表达减弱了凝血酶和OxPAPC引起的EC通透性变化和MLC磷酸化。这些数据表明,在激动剂刺激的不同背景下,纽蛋白与FA或AJ的特异性相互作用是由基于区域肌动球蛋白的张力发展所定义的,并参与了内皮细胞屏障破坏和屏障增强这两种反应。